These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6260864)

  • 41. Comparison of in vitro activity of mecillinam with other antimicrobial chemotherapeutic agents against Salmonella Shigella and El Tor Vibrio cholerae.
    Mhalu FS; Swai V; Runyoro D; Shao JF
    East Afr Med J; 1982 Oct; 59(10):676-81. PubMed ID: 6309499
    [No Abstract]   [Full Text] [Related]  

  • 42. In vitro activity of mecillinam and mecillinam/ampicillin combinations on Proteus species.
    Hone R; Foley M
    J Antimicrob Chemother; 1980 May; 6(3):410-2. PubMed ID: 6249783
    [No Abstract]   [Full Text] [Related]  

  • 43. Synergistic effect of cephalexin with mecillinam.
    Otsuki M
    J Antibiot (Tokyo); 1981 Jun; 34(6):739-52. PubMed ID: 6268594
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical isolates of Escherichia coli solely resistant to mecillinam: prevalence and epidemiology.
    Bousquet A; Bugier S; Larréché S; Bigaillon C; Weber P; Delacour H; Valade E; De Briel D; Mérens A
    Int J Antimicrob Agents; 2018 Mar; 51(3):493-497. PubMed ID: 29154843
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amdinocillin (Mecillinam) resistance mutations in clinical isolates and laboratory-selected mutants of Escherichia coli.
    Thulin E; Sundqvist M; Andersson DI
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1718-27. PubMed ID: 25583718
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Susceptibility testing of urinary isolates of Escherichia coli to mecillinam using NCCLS methodology.
    Skov R; Frimodt-Moller N; Menday P; Espersen F
    Int J Antimicrob Agents; 2005 Mar; 25(3):198-204. PubMed ID: 15737512
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mecillinam alone and in combination with ampicillin or moxalactam in experimental Escherichia coli meningitis.
    Schaad UB; Grimm LM; Beskid G; Cleeland R; Nelson JD; McCracken GH
    Infection; 1982; 10(2):90-6. PubMed ID: 6284652
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High genetic diversity of nitrofurantoin- or mecillinam-resistant Escherichia coli indicates low propensity for clonal spread.
    Poulsen HO; Johansson A; Granholm S; Kahlmeter G; Sundqvist M
    J Antimicrob Chemother; 2013 Sep; 68(9):1974-7. PubMed ID: 23640126
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mecillinam.
    Bakhtiar M; Selwyn S
    Lancet; 1978 Feb; 1(8059):337. PubMed ID: 75379
    [No Abstract]   [Full Text] [Related]  

  • 50. [Sensitivity to FL 1060 (mecilliman) of E. coli and Klebsiella pneumoniae isolated from bile (author's transl)].
    Deguchi K
    Jpn J Antibiot; 1980 Mar; 33(3):329-32. PubMed ID: 6249943
    [No Abstract]   [Full Text] [Related]  

  • 51. Synergic post-antibiotic effect of mecillinam, in combination with other beta-lactam antibiotics in relation to morphology and initial killing.
    Hanberger H; Nilsson LE; Svensson E; Maller R
    J Antimicrob Chemother; 1991 Oct; 28(4):523-32. PubMed ID: 1761447
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of subinhibitory amounts of ampicillin, amoxycillin and mecillinam on the adhesion of Escherichia coli bacteria to human urinary tract epithelial cells: a preliminary study.
    Svanborg-Edén C; Sandberg T; Stenqvist K; Ahlstedt S
    Infection; 1979; 7 Suppl 5():S452-5. PubMed ID: 229079
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In-vitro activity of the combinations of ampicillin with mecillinam or with beta-lactamase inhibitors against strains resistant to ampicillin.
    Verbist L
    J Antimicrob Chemother; 1985 Dec; 16(6):719-25. PubMed ID: 3879248
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In-vitro sensitivity to mecillinam of multiresistant gram-negative rods.
    Chattopadhyay B; Thomas E
    Lancet; 1978 Jan; 1(8057):214-5. PubMed ID: 74642
    [No Abstract]   [Full Text] [Related]  

  • 55. [Sensitivity of Enterobacteriaceae isolated from humans to 6-N,N-1',6'-hexyleneformamidine-penicillanic acid (preparation HX)].
    Zaremba M; Zukowska-Nytko K; Grala-Kałuzna A; Kacprzak-Wiatr A; Piotrowski J; Kulikowska A; borowski J
    Med Dosw Mikrobiol; 1982; 34(1-2):17-26. PubMed ID: 6292593
    [No Abstract]   [Full Text] [Related]  

  • 56. The antibacterial activity of combinations of mecillinam and ampicillin in vitro and in normal and granulopenic mice.
    van der Voet GB; Mattie H; van Furth R
    Scand J Infect Dis; 1983; 15(1):91-6. PubMed ID: 6302832
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Murein and lipopolysaccharide biosynthesis in synchronized cells of Escherichia coli K 12 and the effect of penicillin G, mecillinam and nalidixic acid.
    Essig P; Martin HH; Gmeiner J
    Arch Microbiol; 1982 Sep; 132(3):245-50. PubMed ID: 6293397
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasmid-mediated partial cross-resistance between ampicillin, mecillinam and cefamandole in Salmonella johannesburg and Salmonella typhimurium.
    Chau PY; Ng WS; Ling J; Arnold K
    J Antimicrob Chemother; 1981 Mar; 7(3):245-55. PubMed ID: 6268597
    [No Abstract]   [Full Text] [Related]  

  • 59. [Inhibitory activity of ampicillin and mecillinam on Haemophilus influenzae].
    Dabernat H; Delmas C; Lareng MB
    Pathol Biol (Paris); 1984 May; 32(5):378-80. PubMed ID: 6330648
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Control of cell septation by lateral wall extension in a pH-conditional morphology mutant of Klebsiella pneumoniae.
    Satta G; Canepari P; Botta G; Fontana R
    J Bacteriol; 1980 Apr; 142(1):43-51. PubMed ID: 6246069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.